PASINDU SAMARASINGHE: Open Payments
NPI 1598127003 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 9 payments from 7 companies in 2025. Trend: 2023 $1,131 · 2024 $1,271 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $122 |
| Exact Sciences Corporation | 1 | $122 |
| Novo Nordisk Inc | 3 | $59 |
| Astellas Pharma US Inc | 1 | $21 |
| Verona Pharma, Inc. | 1 | $18 |
Products named: KRYSTEXXA, CAPVAXIVE, TREMFYA, The Cologuard Plus Collection Kit, Wegovy, Veozah, Ohtuvayre.
Industry payments across MD — which companies pay providers there.
